ROME Therapeutics Revenue and Competitors

Boston, MA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • ROME Therapeutics's estimated annual revenue is currently $11.3M per year.(i)
  • ROME Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • ROME Therapeutics has 73 Employees.(i)
  • ROME Therapeutics grew their employee count by -4% last year.

ROME Therapeutics's People

NameTitleEmail/Phone
1
Co-founder, President and CEOReveal Email/Phone
2
CFO and CBOReveal Email/Phone
3
VP, Medicinal ChemistryReveal Email/Phone
4
SVP, FinanceReveal Email/Phone
5
VP ImmunologyReveal Email/Phone
6
VP Structural Biology and BiophysicsReveal Email/Phone
7
VP, Data ScienceReveal Email/Phone
8
SVP, Corporate Development and StrategyReveal Email/Phone
9
EVP, Early DevelopmentReveal Email/Phone
10
VP, Head BiologyReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.3M20%N/AN/A
#3
$5.1M336%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$0.9M60%N/AN/A
#6
$235M300-5%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.4M353%N/AN/A
#10
$1.6M100%N/AN/A
Add Company

What Is ROME Therapeutics?

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome – vast stretches of uncharted genetic material that have long been dismissed as “junk DNA.” With several drug targets identified and multiple discovery programs underway, ROME is moving rapidly to leverage this new frontier in biology. To lead this exploration, ROME has assembled a team of world-class leaders across fields including oncology, immunology, virology and machine learning. ROME was launched in April 2020 and was incubated at GV, in collaboration with ARCH Venture Partners and Partners Innovation Fund. ROME is based in Cambridge, Mass. For more information, please visit www.rometx.com.

keywords:N/A

N/A

Total Funding

73

Number of Employees

$11.3M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

ROME Therapeutics News

2022-04-20 - TED 2022: Bill Gates's idea for preventing future pandemics

“When covid first struck, we were almost like Rome before they had ... therapeutics and vaccines,” Gates said, holding up handheld rapid...

2022-04-06 - HIV drug stabilizes disease progression in metastatic ...

MST is a consultant for ROME therapeutics. JWC is author for McGraw Hill and UpToDate. LG is a consultant/advisory board member for Alentis,...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$11.3M73-42%N/A
#2
$11.4M7318%N/A
#3
$16M736%N/A
#4
$1.7M7346%N/A
#5
$11.8M7318%N/A